Literature DB >> 3678469

The treatment of adult idiopathic thrombocytopenic purpura. Infusion of vinblastine in ITP.

M Simon1, J P Jouet, P Fenaux, J P Pollet, M P Walter, F Bauters.   

Abstract

16 adult idiopathic thrombocytopenic purpura (ITP) patients, with mean age 51 years, were treated by 5 weekly slow intravenous infusions of vinblastine (0.1 mg/kg). When a complete or partial response (CR or PR) was obtained, slow infusions were repeated at 2-weekly then monthly intervals, as maintenance therapy. In 4 cases with ITP of recent onset, but presenting contraindication or failure to prednisone and high dose intravenous immunoglobulins, CR was obtained in all patients after 4 to 15 days (mean 9.5). Only one of these patients relapsed. In 12 cases of refractory chronic ITP (of whom 10 had been splenectomized), there were 2 CR, 6 PR and 4 failures. The 8 responding patients had a mean interval to response of 20 days. The 6 PR were short and did not exceed 15 days. Our results do not support a superiority of this treatment compared to other modes of administration of vinca alkaloids in ITP (intravenous bolus, vinca loaded platelets).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678469     DOI: 10.1111/j.1600-0609.1987.tb00756.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

Review 1.  Current concepts in the treatment of immune thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

2.  Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 cases.

Authors:  P Fenaux; I Quiquandon; M T Caulier; M Simon; M P Walter; F Bauters
Journal:  Blut       Date:  1990-04

Review 3.  Treatments for Primary Immune Thrombocytopenia: A Review.

Authors:  Margot Samson; William Fraser; David Lebowitz
Journal:  Cureus       Date:  2019-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.